METHIMAZOLE TABLETS USP 5 MG
METHIMAZOLE : 5 MG · DIN 02489716 · ENDO OPERATIONS LTD.
Health Canada status: CANCELLED PRE MARKET
What is METHIMAZOLE TABLETS USP?
METHIMAZOLE TABLETS USP 5 MG contains METHIMAZOLE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02489716, held by ENDO OPERATIONS LTD., supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 07-Jul-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02489716 |
|---|---|
| Brand name | METHIMAZOLE TABLETS USP |
| Generic / active ingredient | METHIMAZOLE : 5 MG |
| Manufacturer | ENDO OPERATIONS LTD. |
| Strength | 5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | H03BB02 THIAMAZOLE |
| AHFS class | 68:36.08 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 07-Jul-2023 |
What can be used instead?
Other Canadian products sharing ATC code H03BB02 THIAMAZOLE. 4 of 14 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| JAMP METHIMAZOLE | 10 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02490633 |
| JAMP METHIMAZOLE | 5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02490625 |
| MAR-METHIMAZOLE | 10 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02480115 |
| MAR-METHIMAZOLE | 5 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02480107 |
| APO-METHIMAZOLE | 5 MG | TABLET | APOTEX INC | DORMANT | DIN 02258935 |
| DOM-METHIMAZOLE | 5 MG | TABLET | DOMINION PHARMACAL | CANCELLED PRE MARKET | DIN 02265869 |
| METHIMAZOLE TABLETS USP | 10 MG | TABLET | ENDO OPERATIONS LTD. | CANCELLED PRE MARKET | DIN 02489724 |
| METHIMAZOLE TABLETS USP | 20 MG | TABLET | ENDO OPERATIONS LTD. | CANCELLED PRE MARKET | DIN 02489732 |
| PHL-METHIMAZOLE | 5 MG | TABLET | PHARMEL INC | CANCELLED PRE MARKET | DIN 02265850 |
| PMS-METHIMAZOLE | 5 MG | TABLET | PHARMASCIENCE INC | CANCELLED POST MARKET | DIN 02244323 |
Who else supplies THIAMAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. THIAMAZOLE appears in 22 registered pack listings across 7 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.